Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.51 |
| ▸ | CTSS | P25774 | 12/20 | 0.51 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.42 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CFD | P00746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19236713 | 1.00 | CTSK (0.51) | CTSKCTSSCTSLTSHRSCN9A | |
| SCHEMBL19236699 | 0.94 | CTSK (0.53) | CTSKCTSSCTSLTSHRSCN9A | |
| SCHEMBL29781539 | 0.94 | CTSK (0.53) | CTSKCTSSCTSLTSHRSCN9A | |
| SCHEMBL28803346 | 0.94 | CTSK (0.53) | CTSKCTSSCTSLTSHRSCN9A | |
| SCHEMBL30146876 | 0.89 | CFD (0.52) | CTSKCTSSCTSLSCN9ASCN10A | |
| SCHEMBL19236710 | 0.89 | CFD (0.52) | CTSKCTSSCTSLSCN9ASCN10A | |
| SCHEMBL19236873 | 0.89 | TSHR (0.58) | CTSKCTSSTSHRCYP3A4ALDH1A1 | |
| SCHEMBL30146994 | 0.89 | TSHR (0.58) | CTSKCTSSTSHRCYP3A4ALDH1A1 | |
| SCHEMBL28803175 | 0.88 | CTSS (0.48) | CTSKCTSSCTSLSCN9ASCN10A | |
| SCHEMBL19236696 | 0.88 | CTSS (0.48) | CTSKCTSSCTSLSCN9ASCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115490751-A | Factor D inhibitors | 拜奥克里斯特制药公司 | 2022-12-20 | — | — | CN | disclosed |